Navigation Links
Assisted Living Industry Looks at Future of Alzheimer's
Date:5/14/2008

ALFA Submits Testimony on Alzheimer's Care

WASHINGTON, May 14 /PRNewswire-USNewswire/ -- The nation's leading organization of assisted living providers today urged the Senate Special Committee on Aging to look to assisted living providers for the model of care for victims of Alzheimer's disease.

Richard Grimes, the CEO and President of the Assisted Living Federation of America (ALFA), submitted testimony to the committee as it launched hearings on the impact on Americans of the progressive brain disease.

Grimes said that he was unable to attend the hearing because his stepmother, a longtime sufferer of Alzheimer's, died this week. His 89 year old father cared for her at home for years until her condition grew worse when she moved to an assisted living community where she received excellent care until her death.

In his testimony, Grimes said, "Assisted living providers offer a safe and comfortable option for Alzheimer's suffers. The Assisted Living Federation of America, the trade association representing the nation's leading assisted living providers, is proud of the ground breaking work of its members in creating a humane and secure living environment for the victims of this dreaded disease."

Scientists estimate more than 14 million Americans will suffer from Alzheimer's disease in the next 40 years and half of all people who reach the age of 85 will exhibit some symptoms of the condition. While drugs can slow the progression of the disease, there is no cure. Because victims can live as long as 20 years from this progressive disease, the type and qualify of care is an enormous concern for all Americans.

Assisted living is the fastest growing long term care option in the United States because industry providers work aggressively to meet the needs of an aging population. This relentless focus on meeting customer needs and desires in a homelike residential setting has led to tremendous innovation in caring for indiv
'/>"/>

SOURCE Assisted Living Federation of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Assisted Suicide Proponents Seek to Expand With New 1-800 Suicide Consultations
2. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
3. Californians Against Assisted Suicide: Assisted Suicide Study From Biased Author is Questionable at Best
4. Vulnerable groups are not at higher risk of physician-assisted death
5. Assisted Suicide Wont Up Deaths for Vulnerable Groups: Study
6. American Humane Association Adds Direct Services in Animal-Assisted Activities and Therapy
7. Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities
8. Play by Steve Nash, Assisted by Milk
9. CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis
10. Assisted Living Federation Challenges Presidential Candidates
11. Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 Minor fender benders and serious ... require parties to the accident to respond appropriately to ... and Prevention (CDC) data from 2010, accidents, including car ... In fact, in 2005, automobile accident-related deaths ... more than 2.3 million drivers and passengers receive treatment ...
(Date:5/19/2013)... Columbus, OH (PRWEB) May 19, 2013 ... LLC continue to follow developments in the nation’s first ... The case, underway in Washington State Superior Court, was ... several years after he suffered complications in a robot-assisted ... The Da Vinci robotic surgery lawsuit ...
(Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
(Date:5/18/2013)... 19, 2013 The American Society for Gastrointestinal Endoscopy ... endoscopy during the ninth annual ASGE Crystal Awards on ... ASGE Foundation, this year,s event will begin at ... Fla. , Held in conjunction with Digestive Disease ... in leadership, research and scientific pursuit. The event will ...
(Date:5/18/2013)... Bethesda, MD (May 19, 2013) The American ... announce its 2013 research scholars. This year,s honorees ... in gastroenterology, hepatology or related areas, and with ... , "These young researchers are the future ... young scholars who are paving the way for ...
Breaking Medicine News(10 mins):Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:AGA Research Foundation Research Scholar Awards advance the work of promising gastroenterologists 2
... a specialty,bank consulting firm, has moved its affiliation to ... independent office of,John Hancock Financial Network in Buffalo, NY, ... to the entire network nationally,announced Peter Gordon, President of ... are excited to be able to offer this specialized ...
... In a statewide survey of medical professionals, 38 physician-scientists ... Medical Center (LA BioMed) are honored for being ... issue of Los Angeles magazine. , Key Professional Media, ... professionals to compile the 2008 list of Southern California ...
... of West,Virginia, Inc. and the Nitro Walmart Marketplace are working ... significant,increase for unexpected emergency needs assistance. , ... events, being held this Friday and,Saturday, more than $20,000 in ... food that will help thousands of area families pay bills, ...
... Clinically Proven, Anti-Aging REVALESKIN(R) Skin Care Brand Launches ... and REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment, All Exclusively Formulated ... , CORAL GABLES, ... of the extraordinarily successful introduction of the core ...
... , , NEW YORK, Dec. 4 ... that it has repurchased 640,930 shares of WebMD Class A Common ... LLC, which was acquired by WebMD in December 2006. In ... in cash pursuant to the terms of the previously completed Subimo ...
... Dec. 4 The Perrigo Company,(Nasdaq: PRGO ... Desloratadine tablets (5 mg) has been settled with Perrigo ... been sued for patent infringement of,US Patent Nos. 6100274, ... ANDA,containing a Paragraph IV certification. Under the terms ...
Cached Medicine News:Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 2Health News:John Hancock Financial Network Offers Bank Owned Life Insurance Resource to Its Independent Career Firms Nationally 3Health News:LA BioMed researchers among Southern California Super Doctors 2Health News:UniCare, Walmart Organize Circle of Hope To Help Mountain Mission Meet Increased Demand for Assistance 2Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 2Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 3Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 4Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 5Health News:Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products 6Health News:WebMD Announces Repurchase of 640,930 of its Shares 2Health News:Perrigo Settles Desloratadine Patent Litigation 2Health News:Perrigo Settles Desloratadine Patent Litigation 3
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Patients with active moderate to severe rheumatoid arthritis ... or adalimumab (Humira ® ) and who were actively ... from baseline at week 10, and sustained response through ... 26 results from the RESTART study were presented for ...
... LLC, the image analysis and pattern recognition technology provider, ... of $244,479.25 under the U.S. Government,s Affordable Care Act. ... projects that show significant potential to produce new therapies, ... health care costs or advance the goal of curing ...
Cached Medicine Technology:New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 2New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 3New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 4New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 5New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 6New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 7Parascript Awarded $244,479.25 Affordable Care Act Grant From the U.S. Government 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: